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Transcriptional Upregulation of Nrf2-Dependent
Phase II Detoxification Genes in the Involved
Epidermis of Vitiligo Vulgaris
Vivek T. Natarajan1, Archana Singh2, Avinash A. Kumar2, Pankaj Sharma3, Hemanta K. Kar3,
Laurent Marrot4, Jean-Roch Meunier4, Krishnamurthy Natarajan5, Rajni Rani2 and Rajesh S. Gokhale1,2,6
Oxidative stress is widely believed to be a contributing factor in vitiligo pathogenesis. To explore mechanisms
by which epidermis responds to mounting oxidative stress, we investigated the involvement of phase II
detoxification genes in vitiligo. Phase II detoxification pathways have recently been identified as being
important in the regulation of epidermal skin homeostasis. In this study we show that the key transcription
factor nuclear factor E2–related factor 2 (Nrf2) and the downstream genes NAD(P)H:quinone oxidase-1 (NQO-1),
g-glutamyl cystine ligase catalytic subunit (GCLC), and g-glutamyl cystine ligase modifying subunit (GCLM) are
upregulated in the lesional epidermal skin of subjects with vitiligo vulgaris. The differences between lesional
and nonlesional skin were further investigated by studying the induced expression of Nrf2-dependent
transcripts in skin punch biopsies using curcumin and santalol. Surprisingly, nonlesional skin showed induction
of all transcripts while a similar effect was not observed for the skin punches from the lesional skin. The use of
curcumin and santalol on epidermal cells showed that keratinocytes were more susceptible to apoptosis,
whereas melanocytes induced phase II genes under the same concentrations with negligible apoptosis. Our
studies provide new insights into the role of phase II detoxification pathway in maintaining skin homeostasis
and sustaining redox balance in vitiligo patients.
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INTRODUCTION
Vitiligo is a depigmenting disorder of human skin that is
characterized by localized loss of melanin from the lesional
epidermis (Lei et al., 2002; Spritz, 2008; Schallreuter et al.,
2008a). It is clear that melanocytes—the melanin-synthesizing
cells of the skin—are substantially decreased in vitiligo lesions
(Tobin et al., 2000). Several theories about the etiology of this
complex disorder have been proposed. These include genetic
susceptibility (Spritz, 2008), autoimmunity (Le Poole and
Luiten, 2008), impaired melanocyte migration and/or prolif-
eration (Gauthier et al., 2003), and oxidative stress (Namazi,
2007; Schallreuter et al., 2008b; Kovacs et al., 2009).
Although the exact mechanism is far from clear, attempts
have recently been made to develop a cumulative theory to
explain the origin of the disorder (Dell’anna and Picardo,
2006; Westerhof and d’Ischia, 2007). In this context,
identification of deregulated pathways in vitiligo would enable
a better understanding of the underlying pathophysiology.
Skin is the major target of insult for a broad spectrum of
chemical pollutants and UV rays (Brenner and Hearing,
2008). These toxic factors induce, directly or indirectly, the
production of reactive oxygen species. Reactive oxygen
species include singlet oxygen, superoxide anions, hydroxyl
radicals, and H2O2, all of which are short-lived entities
continuously generated at low levels during the course of
normal aerobic metabolism (Zou and Banerjee, 2005). The
inability of skin to regulate the levels of these species results
in oxidative stress. The breakdown of this homeostasis
defense mechanism in the skin can result in modification of
proteins, lipids, and DNA, which in turn can bring about
several dermatological diseases. To combat this cellular
damage, mammals have evolved elaborate detoxification
machinery associated with the phase I, II, and III classes
of enzymes. The phase II detoxification enzymes are crucial,
as they are directly involved in detoxification reactions of
oxidative stress response (Tirumalai et al., 2002). The key
transcription factor that induces phase II gene expression is
nuclear factor E2–related factor 2 (Nrf2), and it functions by
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binding to the antioxidant response element present in the
promoter of many phase II genes (Motohashi and Yamamoto,
2004; Kensler et al., 2007). One of the important in vivo
regulatory mechanisms involves formation of the Nrf2-Keap1
complex, which is known to regulate cellular defense
mechanisms such as oxidative stress (Wakabayashi et al.,
2003; Nguyen et al., 2009).
Recent studies have identified an important role for the
Nrf2 pathway in maintaining skin homeostasis in epidermis
(Marrot et al., 2008). This pathway operates in both
melanocytes and keratinocytes, enabling skin to adapt to
various environmental stresses. Genetically, Nrf2 promoter
polymorphisms have been associated with an increased risk
of developing vitiligo (Zhou et al., 2008; Guan et al., 2008b).
Altered cellular localization of Nrf2 in lesional vitiligo skin
has also been reported (Guan et al., 2008a). Interestingly,
vitiligo patients seem to exhibit systemic as well as localized
oxidative stress (Passi et al., 1998; Rokos et al., 2002), and
millimolar levels of H2O2 are reported to be present in their
epidermis (Schallreuter, 1999; Shalbaf et al., 2008). Several
antioxidant proteins have been shown to be altered in patient
groups (Ines et al., 2006; Arican and Kurutas, 2008), and
metabolic changes in the skin induced by H2O2 have also
been reported (Schallreuter et al., 2006; Spencer et al., 2007).
A clinical study suggested that narrow-band UVB-activated
pseudocatalase controls H2O2 levels and thus might be
effective for treatment of childhood vitiligo (Schallreuter
et al., 2008b). However, it is currently not clear whether
Nrf2-regulated phase II detoxification machinery has an
important role in vitiligo etiopathogenesis.
In this study, we examined the integrity of the phase II
detoxification pathway in the epidermis of vitiligo patients.
We found that the transcript levels of Nrf2 as well as the
downstream detoxification genes NAD(P)H:quinone oxidase
(NQO-1), g-glutamyl cystine ligase catalytic subunit (GCLC),
and g-glutamyl cystine ligase modulatory subunit (GCLM) are
upregulated in the lesional epidermis compared with the
matched nonlesional skin. Furthermore, we evaluated the
regulation of phase II genes in the punch biopsies from vitiligo
patients as well as in cultured melanocytes and keratinocytes
using the electrophilic compounds curcumin and santalol. Our
study revealed a critical role of the phase II detoxification
pathway in vitiligo and suggests that therapeutic intervention of
this pathway may be useful in management of the disorder.
RESULTS
Expression analyses of phase II detoxification pathway genes
To study the detoxification pathway in vitiligo, nonlesional
and lesional skin biopsies were collected from vitiligo
vulgaris patients after written informed consent and institu-
tional ethical committee clearance had been obtained. The
levels of Nrf2 and phase II detoxification gene transcripts
were compared across the lesional and nonlesional epidermis
of vitiligo patients, and this was considered a measure of
cellular response to the prevailing oxidative stress. Total RNA
was isolated from the lesional and nonlesional epidermis.
Quantitative real-time PCR analysis was carried out to
examine the expression of heme oxygenase-1 (HO-1),
NQO-1, GCLC, and GCLM transcripts. TaqMan probes used
for the experiment were designed at the exon–intron
boundary and have been validated to be mRNA specific
(Marrot et al., 2008). Our preliminary analysis showed that
b-actin mRNA was differentially expressed in vitiligo as
compared with nonlesional skin, and therefore 18S ribosomal
RNA (rRNA) was used as the normalization control in duplex
TaqMan assays. Quantitative PCR analysis was carried out for
each sample in duplicate. Replicates that differed by an SD of
X0.5 were eliminated from the analysis. The DCt value was
defined as the difference between the Ct value for the gene of
interest and that for the endogenous control 18S rRNA. The
DCt values of nonlesional and lesional skin for each of
the patient samples were plotted as a column scatter plot
(Figure 1a). Median DCt values were significantly lower for
the expression of GCLC, GCLM, and NQO-1 in vitiliginous
skin as compared with nonlesional skin (P-value o0.001,
Mann–Whitney test). Interestingly, there was no significant
difference in the HO-1 mRNA levels between nonlesional
and lesional skin in this cohort of vitiligo vulgaris patients.
Paired Student’s t-test for the matched samples of nonlesional
and lesional skin also showed significant trends (P-value
o0.001), confirming upregulation of detoxification genes in
the lesional skin.
To understand the significance of this upregulation, we
also investigated the expression levels in normal and foreskin
epidermis (Figure 1b and c). The DCt values between lesional
and nonlesional samples can be readily compared as these
were obtained from the same subjects. However, the same
criterion cannot be applied to the foreskin and normal skin
samples. With our limited data, it is tempting to speculate
that the foreskin has a higher expression of phase II genes
than normal skin does.
We calculated the fold change in expression of each
matched pair of nonlesional and lesional skin. The lesional skin
of most of the individuals had elevated expression of GCLC,
GCLM, and NQO-1 genes (Figure 1d–f, Table 1), whereas only
3 of 15 individuals showed remarkable elevated expression of
the HO-1 gene (Figure 1g). Although HO-1 is an important
element of the antioxidant response, its regulation has been
shown to be more complex than that of other phase II genes
(Baglole et al., 2008; Numata et al., 2009). The GCLC and
GCLM proteins interact to form the functional g-glutamyl
cystine ligase enzyme, and, accordingly, the elevated GCLC
and GCLM levels in the lesional skin assume functional
significance. The data suggest a definite involvement of
NQO-1, as it was upregulated in the lesional skin in almost
all subjects with a fold change of 42.0.
Expression of Nrf2 in the lesional and nonlesional epidermis
Given that Nrf2 is the upstream transcription factor regulating
the induction of phase II genes upon oxidative stress, we
examined the levels of Nrf2 mRNA in skin punch samples
from vitiligo patients. The DCt values showed a distinctly
higher expression of Nrf2 in the lesional skin as compared
with the nonlesional skin (Figure 2a). The relative Nrf2
levels vary between two- and eightfold in different samples
(Figure 2b). The transcript of Nrf2 was also studied in the
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normal skin and foreskin samples, as shown in Figure 2c. We
further examined the protein expression of Nrf2 in the
epidermis using immunohistochemistry on the skin sections
derived from the foreskin and the nonlesional and lesional
skin (Figure 2d). Interestingly, although the distribution of
Nrf2 in the nonlesional skin is uniform, the lesional skin
showed Nrf2 distribution in patches.
Effect of curcumin and santalol on human melanocytes and
keratinocytes
Enhanced levels of phase II genes indicate a disrupted redox
homeostasis in the vitiligo epidermis. We decided to explore
this further by investigating the effect of induced oxidative
stress response in cultured melanocytes and keratinocytes.
Two common skin-care compounds—curcumin and santalol—
were chosen for this study. Curcumin possesses two phenolic
rings connected by two a,b-unsaturated carbonyl groups
(Figure 3a). Santalol consists of a bicyclic ring system
covalently linked to an aliphatic unsaturated chain containing
a hydroxyl functional group (Figure 3b). Both compounds are
electrophilic and similar to other known phase II gene inducers,
including butylated hydroxyanisol, tert-butylhydroquinone,
green tea polyphenol, ()-epicatechin-3-gallate, and isothio-
cyanates such as sulforaphane (Rushmore et al., 1990).
Curcumin has previously been shown to activate Nrf2 in
several cell types (Jeong et al., 2009; Yang et al., 2009).
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Figure 1. Levels of phase II detoxification gene transcripts are altered in the lesional epidermis as compared with the nonlesional epidermis. (a) Real-time
PCR analyses of GCLC, GCLM, NQO-1, and HO-1 carried out using duplex assays were normalized to 18S ribosomal RNA (rRNA) and represented as a
column scatter plot of DCt values for both nonlesional and lesional skin. The horizontal line shows the median (n¼ 15). **Significant P-value (o0.001), as
calculated using the Mann–Whitney test. DCt values for phase II genes in (b) foreskin and (c) normal epidermis. Fold change with respect to corresponding
nonlesional skin for each vitiligo patient is represented as a bar graph. (d) GCLC, (e) GCLM, (f) NQO-1, and (g) HO-1. Fold change was calculated using
2DDCt, where DDCt represents DCt of lesional–DCt of nonlesional skin. GCLC, g-glutamyl cystine ligase catalytic subunit ; GCLM, g-glutamyl cystine ligase
modulatory subunit ; HO-1, heme oxygenase-1; NQO-1, NAD(P)H:quinone oxidase-1.
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Figure 2. Analysis of nuclear factor E2–related factor 2 (Nrf2) mRNA levels in nonlesional and lesional epidermis. (a) DCt values for Nrf2 determined by
real-time PCR in the nonlesional and the lesional epidermis of vitiligo vulgaris patients. **Significant P-value (o0.005), as calculated using the Mann–Whitney
test. (b) Changes in the expression levels of Nrf2 between the lesional skin and the corresponding nonlesional skin represented as fold change for each vitiligo
patient. (c) DCt values for Nrf2 determined by real-time PCR in the foreskin and normal epidermis. (d) Immunohistochemical analysis of Nrf2 levels in
nonlesional and lesional skin sections and comparison with foreskin. Nrf2 was stained brown using rabbit Nrf2 antibody and developed. Scale bar¼ 10 mm.
Table 1. Details of vitiligo vulgaris patients recruited for the study along with the heat map showing regulation of
phase II detoxification genes in lesional as compared with nonlesional epidermis
Ankle8F10VD48
Shin12F24VD44
Leg9M20VD40
Knee14F28VD39
Forearm6F16VD38
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ID
No
Yes
No
No
Yes
Yes
Yes
No
NA
NA
NA
NA
NA
NA
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1History of psoralen and UVA light therapy.
Abbreviation: NA, not available.
2Log10 of fold difference between involved and uninvolved regions plotted as a heat map.
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Keratinocyte and melanocyte cultures were established
from foreskins derived from healthy donors (Figure 3c and d).
MTT (methylthiazolyldiphenyl-tetrazolium bromide) assays
were performed to determine the optimal concentration of
the compounds, and two concentrations were chosen on the
basis of differences in the viability of these two cell types
(Figure 3e–h). There are indications in the literature to suggest
that cells in the early apoptotic phase are viable and thus are
also positive in the MTT assay (Gomez-Lechon et al., 2002).
Apoptosis assays were performed on melanocytes and
keratinocytes with 12.5 and 25 mM curcumin and 25 and
100mM santalol incubated for 48 hours. To assess the extent of
cell death induced by these two compounds, cell viability
was determined via propidium iodide (PI) and annexin V
staining followed by flow cytometry. The percentage of cells
undergoing apoptosis (PI and annexin V double positive) was
observed to be higher in keratinocytes than in melanocytes
(Figure 4a). Even at low concentrations of curcumin (12.5 mM)
and santalol (25 mM), approximately 50% of the keratinocytes
were alive, whereas at the same concentrations in melano-
cytes the extent of cell death was negligible (Figure 4b).
Although both these cell types were epidermally derived, the
observed responses to chemicals were strikingly different.
To assess the expression levels of Nrf2 and phase II
detoxification genes, cells at 60% confluence were treated
with the chosen concentrations of curcumin and santalol for
48 hours. The Nrf2 mRNA levels showed induced expression
in melanocytes, and no significant change could be observed
in keratinocytes (Figure 4c). For the detoxification genes,
HO-1 showed increased levels in keratinocytes on treatment
with curcumin and santalol (Figure 4d). In contrast, melano-
cytes showed an increase in all four transcript levels
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Figure 3. Cell viability of melanocytes and keratinocytes upon curcumin and santalol treatment. Chemical structures of (a) curcumin and (b) santalol. Bright-
field images of cultured (c) keratinocytes and (d) melanocytes before treatment; scale bar¼ 100 mm. Cell viability measured colorimetrically using the
methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay at various concentrations of curcumin (e) in keratinocytes and (f) in melanocytes and of santalol (g) in
keratinocytes and (h) in melanocytes. Cells were treated with indicated concentrations of the compounds for 48 hours followed by the addition of MTT for the
last 3 hours, and the purple formazan was dissolved in DMSO.
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(Figure 4e). It is tempting to speculate that keratinocytes
succumb to mounting levels of oxidative stress because of
their inability to induce Nrf2. Melanocytes, by virtue of
elevated levels of Nrf2 and also the phase II transcripts,
resisted apoptosis induced by curcumin and santalol.
Effect of curcumin and santalol on lesional and nonlesional
epidermis
Studies on cultured cells in the presence of curcumin and
santalol have shown that both Nrf2 and phase II detoxifica-
tion genes could be induced differentially in the two
epidermis cell types. We therefore decided to investigate
the overall oxidative homeostasis in epidermis using these
two electrophilic reagents. For this experiment we used organ
culture of intact skin biopsies (Lateef et al., 2004). The
biopsies were disinfected with 70% ethanol, rinsed with
antibiotics, and placed in M254 medium containing curcu-
min or santalol for 48 hours. These experiments were
performed with 12.5 mM curcumin and 25mM santalol. Under
these conditions the expression of several housekeeping
genes was minimally perturbed.
In the nonlesional skin, both curcumin and santalol
caused an increase in the levels of all four phase II transcripts
(Figure 5a), although the change in GCLC seems to be
marginal. Interestingly, in the lesional skin these compounds
did not show an analogous increase in the levels of transcripts
(Figure 5b). It seems that the elevated basal levels of phase II
transcripts are not further altered by these compounds. The
foreskin also did not show corresponding changes in the
transcripts as observed for the nonlesional skin (Figure 5c).
Corroborating these observations, corresponding changes in
the Nrf2 levels were also observed in the nonlesional skin
(Figure 5d). Immunohistochemical staining of melanocytes
in the nonlesional and lesional skin shows the differences in
melanocyte numbers for the two matched skins (Figure 5e
and f). Our results thus strongly suggest that the cellular
physiology of lesional epidermis is indeed perturbed in
comparison with nonlesional skin.
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Figure 4. Curcumin and santalol alter nuclear factor E2–related factor 2 (Nrf2) and phase II detoxification transcripts in cultured human melanocytes and
keratinocytes and their effect on apoptosis. Representative flow cytometric density plots of curcumin- and santalol-treated (a) keratinocytes (top) and
melanocytes (bottom) are given. In each panel the lower left quadrant represents unstained live cells, and the lower right and upper right quadrants show early
(annexin V-positive cells) and late (annexin V–propidium iodide (PI)-positive) apoptotic cells, respectively. Upper left quadrant represents PI-positive necrotic
cells. The inset in the upper left quadrant shows the percentages of cells falling in each quadrant. (b) Percentage of total apoptotic cells detected (mean of sum of
early and late apoptotic cells of four samples each) for indicated concentrations of curcumin and santalol. (c) Nrf2 levels measured by real-time PCR for each
concentration of curcumin and santalol in keratinocytes and melanocytes. Effect of curcumin (12.5 and 25 mM) and santalol (25 and 100 mM) on the levels of
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2786 Journal of Investigative Dermatology (2010), Volume 130
VT Natarajan et al.
Homeostasis of Oxidative Stress in Vitiligo
DISCUSSION
Oxidative stress has a significant role in the induction of
several inflammatory skin diseases (Bickers and Athar, 2006).
Increased oxidative stress has also been implicated in the
etiology of depigmented patches in vitiligo (Passi et al., 1998;
Schallreuter, 1999). The transcription factor Nrf2 is known
to regulate the expression of a network of cytopro-
tective enzymes, resulting in protection against toxicity after
exposure to oxidative stress or various electrophilic and
oxidative chemicals. In this study we described the transcrip-
tional activation of Nrf2 as well as downstream phase II
detoxification genes from the lesional regions. Comparative
analysis between lesional and nonlesional skin from the same
individuals across several subjects showed upregulation of
NQO-1, GCLC, and GCLM genes in lesional skin. Interest-
ingly, the expression of HO-1, another phase II detoxification
response gene, is not altered in the majority of individuals.
Indeed, several studies have reported that HO-1 regulation
may be more complex (Zhang et al., 2006; Baglole et al.,
2008). Across all 15 subjects, the lesional level of Nrf2 was
also consistently higher than in the matched nonlesions.
Interestingly, under basal conditions Nrf2 is bound to Keap1
in the cytoplasm, and the dissociation of this complex is
critical to the activation of Nrf2. In certain instances, mRNA
regulation of Nrf2 has also been demonstrated (Gong and
Cederbaum, 2006), and Nrf2 is proposed to autoregulate its
own expression through an antioxidant response element–like
element located in the proximal region of its promoter,
leading to persistent nuclear accumulation of Nrf2 and
protracted induction of phase II genes (Miao et al., 2005).
In this context, consistent upregulation of Nrf2 mRNA and
phase II detoxification genes in lesional skin gains relevance.
We also independently observed that the levels of Nrf2
mRNA and of the detoxification genes seem to be higher in
foreskin samples than in normal skin, based on data from
about five samples. Although the normal skin and foreskin
samples were from unmatched individuals, the consistent
pattern of high Nrf2 expression and lack of induction of phase
II genes suggests that the foreskin may be under high
oxidative stress. Studies using keratinocytes from foreskin
have shown an augmented innate immune response owing to
the presence of microflora (Chung and Dale, 2004). This
could be a reason for the increased Nrf2 and phase II genes
observed in this skin type. For GCLC and GCLM, the median
levels in nonlesional skin were seemingly higher than in
normal epidermis from individuals not suffering from vitiligo.
Although the number of normal samples analyzed was small,
this pattern suggests that the nonlesional skin was also under
oxidative stress, although at a lower level than in the
corresponding lesional skin.
Our results showed that the nonlesional skin was able to
actively respond to the electrophilic compounds curcumin
and santalol and induce a classic Nrf2-dependent antioxidant
response. The lesional punch samples, however, did not
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Figure 5. Effect of curcumin and santalol on whole epidermis. (a) Nonlesional and (b) lesional vitiligo skin biopsies and (c) foreskin were cultured in the
presence of 12.5mM curcumin and 25mM santalol for 48 hours, and the levels of phase II detoxification transcripts were quantitated by real-time PCR in the
epidermis. Error bars represent mean±SEM across four individuals. Dotted line represents a twofold upregulation threshold, which is considered significant.
(d) Fold changes in the nuclear factor E2–related factor 2 (Nrf2) levels upon curcumin and santalol treatment in nonlesional and lesional skin of a vitiligo patient
and in foreskin. Immunohistochemistry using S-100 antibody for detecting melanocytes in the (e) nonlesional and (f) lesional skin of the vitiligo patient.
Dark red–stained cells are S100-positive melanocytes. Scale bar¼ 10 mm.
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respond in an analogous manner. We suggest that this was
due to the elevated levels of phase II genes in the lesional
skin. The effects of curcumin and santalol on keratinocytes
and melanocytes in culture highlight the differential res-
ponses between the two cell types. Whereas keratinocytes do
not respond to the compounds by elevating Nrf2 and phase II
genes and eventually succumb to apoptosis, melanocytes
upregulate the Nrf2 pathway and are well protected. This
suggests an integrated role of Nrf2-dependent phase II genes
in oxidative stress–induced apoptosis. Although the cells
provide a suitable model for studying skin homeostasis, the
clear-cut differences with the skin punch suggest a complex
behavior of this tissue. Thus, our studies using skin punch
biopsies provided an alternative organ model and revealed
oxidative stress regulation in vitiligo.
The roles of Nrf2-dependent pathways have begun to
emerge from various model systems, ranging from pulmonary
disorders to cancer. The beneficial effect of enhanced
Nrf2 effectors seems to be the prime protective function
conferred by this pathway on tissue homeostasis. Apart from
the protective response, it is noteworthy that the conse-
quences of this increased response of phase II genes could be
in sustaining the depigmented lesions in vitiligo patches.
Although oxidative stress in lesional and nonlesional skin
has been reported previously, our study demonstrates the
involvement of Nrf2 and phase II genes during skin
homeostasis in vitiligo. We also showed that nonlesional
pigmented skin from vitiligo patients does not undergo
the same level of oxidative stress. Thus, therapeutic
intervention in this altered oxidative stress pathway may
have significant relevance in the management and treatment
of vitiligo.
MATERIALS AND METHODS
Skin punches used for the experiments were taken from patients
after obtaining informed written consent; the procedure is elaborated
in the Supplementary Methods online. The procedures followed were
approved by the institutional human ethics committee at the National
Institute of Immunology and Dr Ram Manohar at Lohia Hospital, and
were in agreement with the Declaration of Helsinki Principles.
Real-time PCR for phase II detoxification gene transcripts
Gene expression analysis was carried out using the ABI Prism 7000
real-time PCR system (Applied Biosystems, Foster City, CA).
Reactions (10 ml) were carried out in replicates using TaqMan
universal PCR master mix (Applied Biosystems). FAM- and TAMRA-
labeled TaqMan probes used in the study were Hs00157965_m1
(HO-1), Hs00168547_m1 (NQO-1), Hs00155249_m1 (GCLC), and
Hs00157649_m1 (GCLM); normalization was carried out using 18S
rRNA probes labeled with VIC and MGB 4319413E-0710034. For
Nrf2, the primer sequences used were 50-GCTCATACTCTTT
CCGTCGC-30 and 50-ATCATGATGGACTTGGAGC-30 and for 18S
rRNA, 50-CGAAAGCATTTGCCAAGAAT-30 and 50-AGTCGGCATCG
TTTATGGTC-30 were used. Real time PCR was carried out using the
SYBR Green (Fermentas Intl, Ontario, Canada) method. All
quantitative PCR reactions were initiated at 50 1C for 2minutes,
95 1C for 10minutes, followed by a cycling condition of 95 1C for
0.15minutes and 60 1C for 1minute for 40 cycles. The data were
analyzed using SDS 1.2 sequence-detection software (Applied
Biosystems), and Ct values were obtained.
Data analysis
For comparison, the Ct method (DCt value) was used. Ct values were
normalized to their corresponding 18S rRNA levels to obtain DCt
values. The DCt values were calculated by subtracting the value of 18S
RNA from that of the gene of interest. The reactions were performed in
replicates, and DCt values that differed by an SD ofX0.5 between the
replicates were eliminated from further analysis. Comparison of the
median DCt values was carried out using the Mann–Whitney test. Fold
change was calculated using 2DDCt, where DDCt represents DCt of
vitiligo–DCt of nonlesional skin. Changes in expression level were
calculated as fold change in the level of transcript between nonlesional
and lesional skin and normalized to 18S rRNA levels. Paired Student’s
t-test was performed to study the significance of the DCt value pairs. All
statistical analyses performed in this study were carried out using
Graph-Pad Prism software (San Diego, CA).
Apoptosis assay
At 48 hours after the aforesaid treatment, both floating and adherent
cells were harvested and stained with annexin V–FITC and PI as
described by the manufacturer (Annexin V–FITC detection kit,
Promokine, Heidelberg, Germany). In brief, 5ml of annexin V–FITC
and 5ml of PI were added to cells after washing and resuspension in
500ml of binding buffer. The mixture was incubated in the dark for
5minutes at room temperature. FITC and PI fluorescence was
measured using a BD LSR Flow cytometer (BD Biosciences, Franklin
Lake, NJ). Approximately 30,000 cells were analyzed for each
sample. All data analysis was performed using WinMDI version 2.9
software (Joseph Totter, Scripps Research Institute, San Diego, CA).
Immunohistochemistry for Nrf2 and S100
Immunohistochemistry was performed using standard protocols.
Briefly, skin biopsies were fixed with 10% formalin, dehydrated, and
embedded in paraffin. Sections (4mm thick) were placed on
polylysine-coated slides, deparaffinized, hydrated, antigen retrieved
with 10mM citrate buffer pH 6.0, and blocked with 5% normal goat
serum. Slides were stained with rabbit monoclonal antibodies to
Nrf2 (dilution 1:100; Epitomics, Burlingame, CA) and S100 (dilution
1:100; Dako Cytomation, Glostrup, Denmark) for 45minutes at
room temperature. Slides were washed and incubated with labeled
polymer alkaline phosphatase (Dako Cytomation) for 30minutes at
room temperature. Reaction was developed with fast red for Nrf2
staining and with fuchsin for S100 staining for 5minutes each, and
both were counterstained with hematoxylin.
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